Release Date: March 6, 2012
National Institutes of Health (NIH)
The purpose of this Notice is to inform potential applicants of changes in the participation of NIH Institutes, Centers, and Offices (ICOs) in PAR-12-017 Shared Instrumentation Grant Program (S10) .
Background
On December 23, 2011, the National Center for Research Resources (NCRR) was dissolved and the National Center for Advancing Translational Sciences (NCATS) and the Office of Research Infrastructure Programs (ORIP) were established. As indicated in NOT-OD-12-026, all NCRR programs were transferred to other NIH ICOs. Additionally, the responsibility for all Funding Opportunity Announcements (FOAs) in which NCRR participated is being transferred to other ICOs. Please visit the NCRR website for more information regarding the transfer of NCRR programs to other NIH ICOs.
Implementation
The following sections of PAR-12-017 have been revised to reflect the changes that resulted from this reorganization of NIH ICOs.
The Components of Participating Organizations section has been revised to remove NCRR and include ORIP:
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
The Catalog of Federal Domestic Assistance (CFDA) Number section has been revised to reflect the updated list of participating ICOs.
The NCRR CFDA number has been removed: 93.389
The following CFDA number for ORIP has been added: 93.351
The Agency Contacts section has been revised to reflect the updated list of participating ICOs.
Scientific/Research Contact(s)
Abraham Levy, PhD
Shared Instrumentation Program
Division of Construction and Instruments
Office of Research Infrastructure Programs
Division of Program Coordination, Planning, and
Strategic Initiatives
National Institutes of Health
Phone: 301-435-0772
Email: [email protected]
Financial/Grants Management Contact(s)
Gloria Berrios
National Center for Advancing Translational Sciences
National Institutes of Health
Phone: 301-435-0875
Email: [email protected]
All other aspects of this FOA remain unchanged.
Please direct all inquiries to the relevant Agency Contact listed in this Guide Notice.